LIP
TMO icon

Liontrust Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Liontrust Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182M Buy
362,213
+101,547
+39% +$48.7M 2.67% 6
2026
Q1 		$128M Sell
260,666
-104,298
-29% -$56.6M 2.19% 7
2025
Q4 		$211M Sell
364,964
-84,307
-19% -$47.7M 3.14% 4
2025
Q3 		$218M Sell
449,271
-17,191
-4% -$8M 3.18% 5
2025
Q2 		$189M Sell
466,462
-23,928
-5% -$10M 2.71% 6
2025
Q1 		$244M Buy
490,390
+1,693
+0.3% +$917K 3.81% 2
2024
Q4 		$254M Buy
488,697
+81,911
+20% +$45M 3.69% 2
2024
Q3 		$225M Hold
406,786
– – 3.2% 5
2024
Q2 		$225M Sell
406,786
-11,534
-3% -$6.61M 3.2% 5
2024
Q1 		$243M Sell
418,320
-41,134
-9% -$23.1M 3.39% 3
2023
Q4 		$244M Buy
459,454
+50,260
+12% +$24.3M 3.54% 3
2023
Q3 		$207M Buy
409,194
+14,132
+4% +$7.53M 3.31% 5
2023
Q2 		$206M Buy
395,062
+20,824
+6% +$11.2M 2.97% 7
2023
Q1 		$216M Buy
374,238
+27,324
+8% +$15.4M 3.16% 4
2022
Q4 		$191M Sell
346,914
-29,900
-8% -$15.8M 3.34% 5
2022
Q3 		$191M Sell
376,814
-64,800
-15% -$36.3M 3.06% 5
2022
Q2 		$240M Sell
441,614
-53,800
-11% -$29.6M 3.38% 6
2022
Q1 		$293M Buy
495,414
+4,500
+0.9% +$2.59M 3.82% 3
2021
Q4 		$328M Sell
490,914
-54,700
-10% -$34.2M 3.9% 3
2021
Q3 		$312M Buy
+545,614
New +$299M 4.31% 3
2020
Q4 		$148M Buy
+317,514
New +$149M 2.98% 8

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Liontrust Investment Partners's TMO Position: Q2 2026 in Review

Liontrust Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 39% in Q2 2026, buying an estimated $48.7M and bringing the position to 362,213 shares worth $182M. The position accounts for 2.67% of the portfolio, ranked #6.

Liontrust Investment Partners first reported a position in TMO in Q4 2020 and has held it in 21 quarters since. The position peaked at $328M in Q4 2021. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Liontrust Investment Partners held 362,213 shares of Thermo Fisher Scientific worth $182M as of Q2 2026.
  • Liontrust Investment Partners bought 101,547 Thermo Fisher Scientific shares in Q2 2026, an estimated $48.7M.
  • Thermo Fisher Scientific made up 2.67% of Liontrust Investment Partners's portfolio in Q2 2026, its #6 holding.
  • Liontrust Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 21 quarters since.
  • Liontrust Investment Partners's Thermo Fisher Scientific position peaked at $328M in Q4 2021.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.